Phenotypic and genetic heterogeneity in Vibrio cholerae O139 isolated from cholera cases in Delhi, India during 2001-2006

Raikamal Ghosh, Naresh C. Sharma, Kalpataru Halder, Rupak K. Bhadra, Goutam Chowdhury, Gururaja P. Pazhani, Sumio Shinoda, Asish K. Mukhopadhyay, G. Balakrish Nair, Thadavarayan Ramamurthy

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Incidence of epidemic Vibrio cholerae serogroup O139 has declined in cholera endemic countries. However, sporadic cholera caused by V. cholerae O139 with notable genetic changes is still reported from many regions. In the present study, 42 V. cholerae O139 strains isolated from 2001 to 2006 in Delhi, India, were retrospectively analyzed to understand their phenotype and molecular characteristics. The majority of isolates were resistant to ampicillin, furazolidone and nalidixic acid. Though the integrative conjugative element was detected in all the O139 isolates, the 2004-2006 isolates remained susceptible to co-trimoxazole, chloramphenicol, and streptomycin. Cholera toxin genotype 1 was present in the majority of the O139 isolates while few had type 3 or a novel type 4. In the cholera toxin encoding gene (ctx) restriction fragment length polymorphism, the majority of the isolates harbored three copies of CTX element, of which one was truncated. In this study, the ctx was detected for the first time in the small chromosome of V. cholerae O139 and one isolate harbored 5 copies of CTX element, of which 3 were truncated. The ribotype BII pattern was found in most of the O139 isolates. Three V. cholerae O139 isolated in 2001 had a new ribotype BVIII. Pulsed-field gel electrophoresis analysis revealed clonal variation in 2001 isolates compared to the 2004-2006 isolates. Molecular changes in V. cholerae O139 have to be closely monitored as this information may help in understanding the changing genetic features of this pathogen in relation to the epidemiology of cholera.

Original languageEnglish
Article number1250
JournalFrontiers in Microbiology
Volume7
Issue numberAUG
DOIs
Publication statusPublished - Aug 9 2016
Externally publishedYes

Fingerprint

Vibrio cholerae O139
Genetic Heterogeneity
Cholera
India
Ribotyping
Cholera Toxin
Furazolidone
Nalidixic Acid
Pulsed Field Gel Electrophoresis
Sulfamethoxazole Drug Combination Trimethoprim
Streptomycin
Chloramphenicol
Ampicillin
Restriction Fragment Length Polymorphisms
Epidemiology
Chromosomes
Genotype
Phenotype
Incidence

Keywords

  • CT genotype
  • CTX prophage
  • PFGE
  • Ribotypes
  • V. cholerae O139

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Ghosh, R., Sharma, N. C., Halder, K., Bhadra, R. K., Chowdhury, G., Pazhani, G. P., ... Ramamurthy, T. (2016). Phenotypic and genetic heterogeneity in Vibrio cholerae O139 isolated from cholera cases in Delhi, India during 2001-2006. Frontiers in Microbiology, 7(AUG), [1250]. https://doi.org/10.3389/fmicb.2016.01250

Phenotypic and genetic heterogeneity in Vibrio cholerae O139 isolated from cholera cases in Delhi, India during 2001-2006. / Ghosh, Raikamal; Sharma, Naresh C.; Halder, Kalpataru; Bhadra, Rupak K.; Chowdhury, Goutam; Pazhani, Gururaja P.; Shinoda, Sumio; Mukhopadhyay, Asish K.; Balakrish Nair, G.; Ramamurthy, Thadavarayan.

In: Frontiers in Microbiology, Vol. 7, No. AUG, 1250, 09.08.2016.

Research output: Contribution to journalArticle

Ghosh, R, Sharma, NC, Halder, K, Bhadra, RK, Chowdhury, G, Pazhani, GP, Shinoda, S, Mukhopadhyay, AK, Balakrish Nair, G & Ramamurthy, T 2016, 'Phenotypic and genetic heterogeneity in Vibrio cholerae O139 isolated from cholera cases in Delhi, India during 2001-2006', Frontiers in Microbiology, vol. 7, no. AUG, 1250. https://doi.org/10.3389/fmicb.2016.01250
Ghosh, Raikamal ; Sharma, Naresh C. ; Halder, Kalpataru ; Bhadra, Rupak K. ; Chowdhury, Goutam ; Pazhani, Gururaja P. ; Shinoda, Sumio ; Mukhopadhyay, Asish K. ; Balakrish Nair, G. ; Ramamurthy, Thadavarayan. / Phenotypic and genetic heterogeneity in Vibrio cholerae O139 isolated from cholera cases in Delhi, India during 2001-2006. In: Frontiers in Microbiology. 2016 ; Vol. 7, No. AUG.
@article{d8ecf11cf5184192a8a36ff3ac39393c,
title = "Phenotypic and genetic heterogeneity in Vibrio cholerae O139 isolated from cholera cases in Delhi, India during 2001-2006",
abstract = "Incidence of epidemic Vibrio cholerae serogroup O139 has declined in cholera endemic countries. However, sporadic cholera caused by V. cholerae O139 with notable genetic changes is still reported from many regions. In the present study, 42 V. cholerae O139 strains isolated from 2001 to 2006 in Delhi, India, were retrospectively analyzed to understand their phenotype and molecular characteristics. The majority of isolates were resistant to ampicillin, furazolidone and nalidixic acid. Though the integrative conjugative element was detected in all the O139 isolates, the 2004-2006 isolates remained susceptible to co-trimoxazole, chloramphenicol, and streptomycin. Cholera toxin genotype 1 was present in the majority of the O139 isolates while few had type 3 or a novel type 4. In the cholera toxin encoding gene (ctx) restriction fragment length polymorphism, the majority of the isolates harbored three copies of CTX element, of which one was truncated. In this study, the ctx was detected for the first time in the small chromosome of V. cholerae O139 and one isolate harbored 5 copies of CTX element, of which 3 were truncated. The ribotype BII pattern was found in most of the O139 isolates. Three V. cholerae O139 isolated in 2001 had a new ribotype BVIII. Pulsed-field gel electrophoresis analysis revealed clonal variation in 2001 isolates compared to the 2004-2006 isolates. Molecular changes in V. cholerae O139 have to be closely monitored as this information may help in understanding the changing genetic features of this pathogen in relation to the epidemiology of cholera.",
keywords = "CT genotype, CTX prophage, PFGE, Ribotypes, V. cholerae O139",
author = "Raikamal Ghosh and Sharma, {Naresh C.} and Kalpataru Halder and Bhadra, {Rupak K.} and Goutam Chowdhury and Pazhani, {Gururaja P.} and Sumio Shinoda and Mukhopadhyay, {Asish K.} and {Balakrish Nair}, G. and Thadavarayan Ramamurthy",
year = "2016",
month = "8",
day = "9",
doi = "10.3389/fmicb.2016.01250",
language = "English",
volume = "7",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media S. A.",
number = "AUG",

}

TY - JOUR

T1 - Phenotypic and genetic heterogeneity in Vibrio cholerae O139 isolated from cholera cases in Delhi, India during 2001-2006

AU - Ghosh, Raikamal

AU - Sharma, Naresh C.

AU - Halder, Kalpataru

AU - Bhadra, Rupak K.

AU - Chowdhury, Goutam

AU - Pazhani, Gururaja P.

AU - Shinoda, Sumio

AU - Mukhopadhyay, Asish K.

AU - Balakrish Nair, G.

AU - Ramamurthy, Thadavarayan

PY - 2016/8/9

Y1 - 2016/8/9

N2 - Incidence of epidemic Vibrio cholerae serogroup O139 has declined in cholera endemic countries. However, sporadic cholera caused by V. cholerae O139 with notable genetic changes is still reported from many regions. In the present study, 42 V. cholerae O139 strains isolated from 2001 to 2006 in Delhi, India, were retrospectively analyzed to understand their phenotype and molecular characteristics. The majority of isolates were resistant to ampicillin, furazolidone and nalidixic acid. Though the integrative conjugative element was detected in all the O139 isolates, the 2004-2006 isolates remained susceptible to co-trimoxazole, chloramphenicol, and streptomycin. Cholera toxin genotype 1 was present in the majority of the O139 isolates while few had type 3 or a novel type 4. In the cholera toxin encoding gene (ctx) restriction fragment length polymorphism, the majority of the isolates harbored three copies of CTX element, of which one was truncated. In this study, the ctx was detected for the first time in the small chromosome of V. cholerae O139 and one isolate harbored 5 copies of CTX element, of which 3 were truncated. The ribotype BII pattern was found in most of the O139 isolates. Three V. cholerae O139 isolated in 2001 had a new ribotype BVIII. Pulsed-field gel electrophoresis analysis revealed clonal variation in 2001 isolates compared to the 2004-2006 isolates. Molecular changes in V. cholerae O139 have to be closely monitored as this information may help in understanding the changing genetic features of this pathogen in relation to the epidemiology of cholera.

AB - Incidence of epidemic Vibrio cholerae serogroup O139 has declined in cholera endemic countries. However, sporadic cholera caused by V. cholerae O139 with notable genetic changes is still reported from many regions. In the present study, 42 V. cholerae O139 strains isolated from 2001 to 2006 in Delhi, India, were retrospectively analyzed to understand their phenotype and molecular characteristics. The majority of isolates were resistant to ampicillin, furazolidone and nalidixic acid. Though the integrative conjugative element was detected in all the O139 isolates, the 2004-2006 isolates remained susceptible to co-trimoxazole, chloramphenicol, and streptomycin. Cholera toxin genotype 1 was present in the majority of the O139 isolates while few had type 3 or a novel type 4. In the cholera toxin encoding gene (ctx) restriction fragment length polymorphism, the majority of the isolates harbored three copies of CTX element, of which one was truncated. In this study, the ctx was detected for the first time in the small chromosome of V. cholerae O139 and one isolate harbored 5 copies of CTX element, of which 3 were truncated. The ribotype BII pattern was found in most of the O139 isolates. Three V. cholerae O139 isolated in 2001 had a new ribotype BVIII. Pulsed-field gel electrophoresis analysis revealed clonal variation in 2001 isolates compared to the 2004-2006 isolates. Molecular changes in V. cholerae O139 have to be closely monitored as this information may help in understanding the changing genetic features of this pathogen in relation to the epidemiology of cholera.

KW - CT genotype

KW - CTX prophage

KW - PFGE

KW - Ribotypes

KW - V. cholerae O139

UR - http://www.scopus.com/inward/record.url?scp=84989213209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989213209&partnerID=8YFLogxK

U2 - 10.3389/fmicb.2016.01250

DO - 10.3389/fmicb.2016.01250

M3 - Article

VL - 7

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

IS - AUG

M1 - 1250

ER -